Crystalline and Amorphous Formulations Used to Deliver Anti-Fibrotic (and other) Compounds in Conjunction with Implanted Materials (Cells/Devices)
Invention type: Technology
/
Case number: #18287J
The present invention provides, in certain embodiments, compositions comprising a uniform population of free, single crystals of a hydrophobic compound. Methods of administering, and processes for preparing, compositions comprising a uniform population of free, single crystals of a hydrophobic compound are also provided.
Researchers
Robert Langer
/
Shady Farah
/
Joshua Doloff
/
Daniel Anderson
Departments: Office of the Institute Professors, Department of Chemical Engineering
Technology Areas: Chemicals & Materials: Composites / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Small Molecules
Impact Areas: Healthy Living, Advanced Materials
-
compositions of crystallized hydrophobic compounds and methods of making and using same
United States of America | Granted | 10,851,069
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.